Relating to access to certain investigational drugs, biological products, and devices that are in clinical trials by patients with severe chronic diseases.
Relating to the use, possession, delivery, or manufacture of testing equipment that identifies the presence of fentanyl, alpha-methylfentanyl, or any other derivative of fentanyl.